Associate Professor Linda Gowing

Linda Gowing
Associate Professor
Adelaide Medical School
Faculty of Health and Medical Sciences

I am a Principal Research Officer with Drug and Alcohol Services South Australia, and an Associate Professor in the Discipline of Pharmacology.

I have been working in the area of evidence-based practice in the treatment of addiction since 1998. I have substantial experience in the preparation of systematic reviews, including Cochrane reviews, and evidence-based guidelines. I am the primary author of five Cochrane reviews, four on approaches to the management of opioid withdrawal, and one on substitution treatment of opioid dependence for prevention of HIV. I have also been a mentor for researchers in Thailand, China, USA and Australia, helping them to become familiar with the systematic review process and undertake their own Cochrane reviews on the treatment of alcohol and other drug use.

The dissemination of the findings of systematic reviews in a form that promotes adoption of the findings is another area of interest that has resulted in monographs on the effectiveness of interventions for illicit drug use and pharmacotherapies for relapse prevention treatment of alcohol dependence as well as journal articles on the management of opioid withdrawal. Most recently I was involved in revision of the national policy and guidelines on medication assisted treatment for opioid dependence in Australia.

I am also involved in teaching in the area of addiction, including through the International Program on Addiction Studies, and a Massive Online Open Course on Managing Addiction that was hosted on EdX in 2015.

Connect With Me

External Profiles

Associate Professor Linda Gowing

I am a Principal Research Officer with Drug and Alcohol Services South Australia, and an Associate Professor in the Discipline of Pharmacology.

I have been working in the area of evidence-based practice in the treatment of addiction since 1998. I have substantial experience in the preparation of systematic reviews, including Cochrane reviews, and evidence-based guidelines. I am the primary author of five Cochrane reviews, four on approaches to the management of opioid withdrawal, and one on substitution treatment of opioid dependence for prevention of HIV. I have also been a mentor for researchers in Thailand, China, USA and Australia, helping them to become familiar with the systematic review process and undertake their own Cochrane reviews on the treatment of alcohol and other drug use.

The dissemination of the findings of systematic reviews in a form that promotes adoption of the findings is another area of interest that has resulted in monographs on the effectiveness of interventions for illicit drug use and pharmacotherapies for relapse prevention treatment of alcohol dependence as well as journal articles on the management of opioid withdrawal. Most recently I was involved in revision of the national policy and guidelines on medication assisted treatment for opioid dependence in Australia.

I am also involved in teaching in the area of addiction, including through the International Program on Addiction Studies, and a Massive Online Open Course on Managing Addiction that was hosted on EdX in 2015.

Appointments

Date Position Institution name
2013 Affiliate Graduate Faculty Member Virginia Commonwealth University
2003 Associate Professor University of Adelaide
1998 - 2008 Lecturer, Level B Flinders University
1998 - 2004 Honorary Visiting Fellow University of New South Wales

Education

Date Institution name Country Title
1987 Australian National University Australia PhD
1982 Massey University New Zealand Bachelor of Science with First Class Honours

Research Interests

Epidemiology, Public Health, Substance Abuse

Journals

Year Citation
2017 Saulle, R., Vecchi, S. & Gowing, L. (2017). Supervised dosing with a long-acting opioid medication in the management of opioid dependence. Cochrane Database of Systematic Reviews, 2017, 4, -. 10.1002/14651858.CD011983.pub2
2017 Gowing, L., Ali, R., White, J. & Mbewe, D. (2017). Buprenorphine for managing opioid withdrawal. Cochrane Database of Systematic Reviews, 2017, 2, 1-95. 10.1002/14651858.CD002025.pub5
2017 Gowing, L., Ali, R. & White, J. (2017). Opioid antagonists with minimal sedation for opioid withdrawal. Cochrane Database of Systematic Reviews, 2017, 5, -. 10.1002/14651858.CD002021.pub4
2016 Gates, P., Sabioni, P., Copeland, J., Le Foll, B. & Gowing, L. (2016). Psychosocial interventions for cannabis use disorder. Cochrane Database of Systematic Reviews, 2016, 5, CD005336-1-CD005336-132. 10.1002/14651858.CD005336.pub4
2016 Nielsen, S., Larance, B., Degenhardt, L., Gowing, L., Kehler, C. & Lintzeris, N. (2016). Opioid agonist treatment for pharmaceutical opioid dependent people. Cochrane Database of Systematic Reviews, 2016, 5, CD011117-1-CD011117-17. 10.1002/14651858.CD011117.pub2
2016 Gowing, L., Farrell, M., Ali, R. & White, J. (2016). Alpha2-adrenergic agonists for the management of opioid withdrawal. Cochrane Database of Systematic Reviews, 2016, 5, -. 10.1002/14651858.CD002024.pub5
2015 Gowing, L. (2015). Identifying corrections-is there a better way?. Addiction, 110, 7, 1207-1207. 10.1111/add.12924
2015 Cusack, L., Kelly, J., Harland, J., Gowing, L., Grønkjaer, M. & Whitaker, N. L. (2015). Alcohol and drug screening for older Australians. Australian Nursing and Midwifery Journal, 22, 7, 41-41.
2015 Gowing, L., Ali, R., Allsop, S., Marsden, J., Turf, E., West, R. & Witton, J. (2015). Global statistics on addictive behaviours: 2014 status report. Addiction, 110, 6, 904-919. 10.1111/add.12899
2015 Gowing, L. & West, R. (2015). Reply to Warnakulasuriya et al.. Addiction, 110, 9, 1533-1534. 10.1111/add.13002
2014 Larney, S., Gowing, L., Mattick, R., Farrell, M., Hall, W. & Degenhardt, L. (2014). A systematic review and meta-analysis of naltrexone implants for the treatment of opioid dependence. Drug and Alcohol Review, 33, 2, 115-128. 10.1111/dar.12095
2014 Gowing, L., Farrell, M., Ali, R. & White, J. (2014). Alpha2-adrenergic agonists for the management of opioid withdrawal (review). The Cochrane database of systematic reviews, 3, 3, CD002024-1-CD002024-87. 10.1002/14651858.CD002024.pub4
2014 Marshall, K., Gowing, L., Ali, R. & Le Foll, B. (2014). Pharmacotherapies for cannabis dependence. The Cochrane database of systematic reviews, 12, 12, CD008940-CD008940. 10.1002/14651858.CD008940.pub2
2013 Gowing, L., Hickman, M. & Degenhardt, L. (2013). Mitigating the risk of HIV infection with opioid substitution treatment. Bulletin of the World Health Organization, 91, 2, 148-149. 10.2471/BLT.12.109553
2013 Rees, E. & Gowing, L. (2013). Supplementary thiamine is still important in alcohol dependence. Alcohol and Alcoholism, 48, 1, 88-92. 10.1093/alcalc/ags120
2012 Gowing, L. (2012). The role of opioid substitution treatment in reducing HIV transmission: risks for drug users and the wider community are substantially reduced. BMJ, 345, 7879, e6425-1-e6425-2. 10.1136/bmj.e6425
2012 Pan, S., Gowing, L., Li, C. & Zhao, M. (2012). Contingency management for substance use disorders (Protocol). The Cochrane Database of Systematic Reviews, 8, 1-13. 10.1002/14651858.CD010029
2012 Farrell, M., Wodak, A. & Gowing, L. (2012). Maintenance drugs to treat opioid dependence. BMJ (Online), 344, 7859, 1-5. 10.1136/bmj.e2823
2011 Gowing, L., Farrell, M., Bornemann, R., Sullivan, L. & Ali, R. (2011). Oral substitution treatment of injecting opioid users for prevention of HIV infection (Review). The Cochrane Database of Systematic Reviews, 8, 004145-1-004145-116. 10.1002/14651858.CD004145.pub4
2010 Gowing, L., Ali, R. & White, J. (2010). Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal. The Cochrane Database of Systematic Reviews, 1, -. 10.1002/14651858.CD002022.pub3
2009 Gowing, L., Farrell, M., Ali, R. & White, J. (2009). Alpha₂-adrenergic agonists for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews, Online, 2, 1-87. 10.1002/14651858.CD002024.pub3
2009 Gowing, L., Ali, R. & White, J. (2009). Buprenorphine for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), 3, -. 10.1002/14651858.CD002025.pub3
2009 Ali, R., Burrows, D., Gowing, L., Vial, R., Walsh, N., Onyancha, P. & Finnerty, E. (2009). Review of Global Policy Architecture and Country Level Practice on HIV/AIDS and Drug Treatment. -.
2009 Gowing, L., Ali, R. & White, J. (2009). Buprenorphine for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews, 2009, 3, 1-76. 10.1002/14651858.CD002025.pub4
2009 Gowing, L., Ali, R. & White, J. (2009). Opioid antagonists with minimal sedation for opioid withdrawal. The Cochrane Database of Systematic Reviews, 2009, 4, 1-47. 10.1002/14651858.CD002021.pub3
2008 Gowing, L., Farrell, M., Bornemann, R., Sullivan, L. & Ali, R. (2008). Substitution treatment of injecting opioid users for prevention of HIV infection. The Cochrane Database of Systematic Reviews, 2009, 2, 1-102. 10.1002/14651858.CD004145.pub3
2006 Gowing, L., Ali, R. & White, J. (2006). Opioid antagonists with minimal sedation for opioid withdrawal (review). The Cochrane Database of Systematic Reviews, Online, 1AR CD002021DI ARTN CD002021, 2021-2021. 10.1002/14651858.CD002021.pub2
2006 Gowing, L. & Ali, R. (2006). The place of detoxification in treatment of opioid dependence. Current Opinion in Psychiatry, 19, 3, 266-270. 10.1097/01.yco.0000218596.54054.a1
2006 Gowing, L., Ali, R. & White, J. (2006). Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal (review). The Cochrane Database of Systematic Reviews, Online, Issue 2. Art. No. CD002022, 1-26. 10.1002/14651858.CD002022.pub2
2006 Gowing, L., Farrell, M., Bornemann, R., Sullivan, L. & Ali, R. (2006). Methadone treatment of injecting opioid users for prevention of HIV infection. Journal of General Internal Medicine (online), 21, 2, 193-195. 10.1111/j.1525-1497.2005.00287.x
2005 Farrell, M., Gowing, L., Marsden, J., Ling, W. & Ali, R. (2005). Effectiveness of drug dependence treatment in HIV prevention. International Journal of Drug Policy, 16S, SUPPL. 1, S67-S75. 10.1016/j.drugpo.2005.02.008
2004 Gowing, L., Ali, R. & White, J. (2004). Buprenorphine for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), 4, CD002025-. 10.1002/14651858.cd002025.pub2
2004 Gowing, L. & Lopatko, O. (2004). Office based treatment with buprenorphine plus naloxone, or buprenorphine alone reduces opiate use and craving: Commentary. Evidence-Based Mental Health, 7, 2, 54-. 10.1136/ebmh.7.2.54
2004 Shearer, J. & Gowing, L. (2004). Pharmacotherapies for problematic psychostimulant use: A review of current research. Drug and Alcohol Review, 23, 2, 203-211. 10.1080/09595230410001704190
2004 Gowing, L., Farrell, M., Bornemann, R. & Ali, R. (2004). Substitution treatment of injecting opioid users for prevention of HIV infection. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 4, -. 10.1002/14651858.CDO04145.pub2
2004 Kaya, C., Tugai, Y., Filar, J., Agrawal, M., Ali, R., Gowing, L. & Cooke, R. (2004). Heroin users in Australia: population trends. Drug and Alcohol Review, 23, 1, 107-116. 10.1080/09595230410001645600
2004 Gowing, L., Farrell, M., Bornemann, R. & Ali, R. (2004). Substitution treatment of injecting opioid users for prevention of HIV infection.. Cochrane database of systematic reviews (Online), 4, CD004145-. 10.1002/14651858.cd004145.pub2
2004 Gowing, L., Farrell, M., Ali, R. & White, J. (2004). Alpha2 adrenergic agonists for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online : Update Software), 4, -. 10.1002/14651858.CD002024.pub2
2003 Ali, R., Thomas, P., White, J., McGregor, C., Danz, C., Gowing, L. ... Athanasos, P. (2003). Antagonist-precipitated heroin withdrawal under anaesthetic prior to maintenance naltrexone treatment: determinants of withdrawal severity. Drug and Alcohol Review, 22, 4, 425-431. 10.1080/09595230310001613949
2003 Gowing, L., Farrell, M., Ali, R. & White, J. (2003). Alpha2 adrenergic agonists for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), 2, CD002024-. 10.1002/14651858.cd002024
2002 Gowing, L., Henry-Edwards, S., Irvine, R. & Ali, R. (2002). The health effects of ecstasy: a literature review. DRUG AND ALCOHOL REVIEW, 21, 1, 53-63. 10.1080/0959230220119363
2002 Gowing, L., Ali, R. & White, J. (2002). Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal.. Cochrane database of systematic reviews (Online), 2, CD002022-. 10.1002/14651858.cd002022.pub2
2002 Gowing, L., Ali, R. & White, J. (2002). Buprenorphine for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), 2, CD002025-. 10.1002/14651858.cd002025
2002 Gowing, L., Henry-Edwards, S., Irvine, R. & Ali, R. (2002). The health effects of ecstacy: a literature review. Drug and Alcohol Review, 21, 1, 53-63. 10.1080/09595230220119363
2002 Gowing, L., Ali, R. & White, J. (2002). Opioid antagonists with minimal sedation for opioid withdrawal.. Cochrane database of systematic reviews (Online : Update Software), 2, CD002021-. 10.1002/14651858.cd002021
2002 Gowing, L., Ali, R. & White, J. (2002). Which substitution pharmacotherapy is most effective in treating opioid dependence?. Medical Journal of Australia, 176, 10, 493-494.
2002 McGregor, C., Ali, R., White, J., Thomas, P. & Gowing, L. (2002). A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months. Drug and Alcohol Dependence, 68, 1, 5-14. 10.1016/S0376-8716(02)00077-7
2002 Gowing, L., Ali, R. & White, J. (2002). Buprenorphine for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews, 2, CD002025-1-CD002025-22. 10.1002/14651858.CD002025
2002 Gowing, L., Farrell, M., Ali, R. & White, J. (2002). a₂-Adrenergic agonists in opioid withdrawal. Addiction, 97, 1, 49-58. 10.1046/j.1360-0443.2002.00037.x
2001 Gowing, L., Ali, R. & White, J. (2001). Buprenorphine for the management of opioid withdrawal. Praxis, 90, 44, 1934-.
2001 Gowing, L., Ali, R. & White, J. (2001). Opioid antagonists under sedation or anaesthesia for opioid withdrawal.. Cochrane database of systematic reviews (Online), 1, CD002022-. 10.1002/14651858.cd002022
2001 Gowing, L., Farrell, M., Ali, R. & White, J. (2001). Alpha2 adrenergic agonists for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), 1, CD002024-. 10.1002/14651858.cd002024
2000 Gowing, L., Ali, R. & White, J. (2000). Opioid antagonists and adrenergic agonists for the management of opioid withdrawal. Praxis, 89, 44, 1810-1811.
2000 Gowing, L., Ali, R. & White, J. (2000). Opioid antagonists and adrenergic agonists for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews, 2, 1-2. 10.1002/14651858.CD002021.pub2
2000 Gowing, L., Ali, R. & White, J. (2000). The management of opioid withdrawal. Drug and Alcohol Review, 19, 3, 309-318. 10.1080/713659366
2000 Gowing, L., Ali, R. & White, J. (2000). Systematic review processes and the management of opioid withdrawal. Australian and New Zealand Journal of Public Health, 24, 4, 427-431. 10.1111/j.1467-842X.2000.tb01606.x
1998 Gowing, L., Ali, R., Christie, P. & White, J. (1998). Therapeutic use of cannabis: clarifying the debate. Drug and Alcohol Review, 17, 4, 445-452. 10.1080/09595239800187281
1985 Gowing, L. R., Tellam, R. L. & Banyard, M. R. C. (1985). Actin synthesis in tumorigenic and non-tumorigenic human hybrid cells. Journal of Cell Science, 76, 255-267.
1984 Robertson, J. G., Thomas, J. E., Gowing, L. R. & Boland, M. J. (1984). Mg++ Adenosine Triphosphatase from Cell Envelopes of Free-Living and Bacteroid Forms of Rhizobium lupini Strain NZP2257. Archives of Biochemistry and Biophysics, 232, 337-347.
1984 Gowing, L. R., Tellam, R. L. & Banyard, M. R. C. (1984). Microfilament organization and total actin content are decreased in hybrids derived from the fusion of HeLa Cells with human fibroblasts. Journal of Cell Science, 69, 137-146.

Book Chapters

Year Citation
2016 Ali, R., Gowing, L. & Harland, J. (2016). The Ultrarapid Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST-Lite) and Implications for Neuropathology. In V. Preedy (Ed.), Neuropathology of Drug Addictions and Substance Misuse, Volume 1: Foundations of Understanding, Tobacco, Alcohol, Cannabinoids and Opioids (pp. 649-659). United Kingdom: Elsevier. 10.1016/B978-0-12-800213-1.00060-2
2015 Ali, R., Gowing, L. R. & Harland, J. (2015). Screening and brief interventions. In P. Haber, C. Day & M. Farrell (Eds.), Addiction Medicine: Principles and Practice (pp. 126-142). Melbourne: IP Communications.
2009 Lintzeris, N., Gowing, L. & Bell, J. (2009). Services for heroin withdrawal: A review. In R. P. Mattick, R. Ali & N. Lintzeris (Eds.), Pharmacotherapies for the Treatment of Opioid Dependence: Efficacy, Cost-Effectiveness and Implementation Guidelines (pp. 54-106). New York, USA: Informa.
2009 Henry-Edwards, S., Gowing, L., White, J., Ali, R., Bell, J., Brough, J. ... Quigley, A. (2009). Clinical guidelines and procedures for the use of methadone in the maintenance treatment of opioid dependence. In R. P. Mattick, R. Ali & N. Lintzeris (Eds.), Pharmacotherapies for the Treatment of Opioid Dependence: Efficacy, Cost-Effectiveness and Implementation Guidelines (pp. 354-389). New York, USA: Informa.
2009 Lintzeris, N., Clark, N., Muhleisen, P., Ritter, A., Ali, R., Bell, J. ... White, J. (2009). National clinical guidelines and procedures for the use of buprenorphine in the treatment of heroin dependence. In R. P. Mattick, R. Ali & N. Lintzeris (Eds.), Pharmacotherapies for the Treatment of Opioid Dependence: Efficacy, Cost-Effectiveness and Implementation Guidelines (pp. 390-445). New York, USA: Informa.

Conference Papers

Year Citation
2016 Gates, P., Sabioni, P., Copeland, J., Le Foll, B. & Gowing, L. (2016). Psychosocial interventions for cannabis use disorder. Australasian Professional Society on Alcohol and other Drugs Conference 2016. Sydney, Australia. 10.1111/dar.12484

Conference Items

Year Citation
2016 Gowing, L. & Larney, S. (2016). SUSTAINED-RELEASE PREPARATIONS OF NALTREXONE FOR THE TREATMENT OF ALCOHOL AND OPIOID DEPENDENCE: CURRENT STATUS.
2012 Ali, R. & Gowing, L. (2012). SYMPOSIUM - NATIONAL POLICY AND GUIDELINES FOR THE PHARMACOLOGICAL TREATMENT OF OPIOID DEPENDENCE.
2012 Gowing, L. (2012). MEDICATIONS FOR ALCOHOL DEPENDENCE: MECHANISMS, EFFECTIVENESS AND FUTURE DIRECTIONS.
2012 Rees, E. & Gowing, L. (2012). Thiamine in alcohol dependence. Australasian Professional Society on Alcohol and other Drugs Conference 2012. Melbourne, Victoria. 10.1111/j.1465-3362.2012.00514.x

Recorded/Rendered Creative Works

Year Citation
2015 Buisman-Pijlman, F. T., Gowing, L., Ali, R. & Salem, A.; (2015); Managing Addiction: A Framework for Successful Treatment; YouTube;

Editorial Boards

Date Role Editorial Board Name Country
2012 - ongoing Board Member Cochrane Collaboration Drugs and Alcohol Group
2005 - ongoing Associate Editor Addiction
2001 - 2012 Associate Editor Cochrane Collaboration Drugs and Alcohol Group
Position
Associate Professor
Phone
83138055
Campus
North Terrace
Building
Medical School North
Room Number
5 11b
Org Unit
Medical Sciences

top